Harmonization of criteria and terminology in fetal rat skeletal evaluations

Author:

Posobiec L. M.1ORCID,Kopp C.2,Murzyn S. M.1,Olitan T.3,Rendemonti J.1,French J.4,Tamborini E.5,Campey J.6,Longo M.5,Danberry T.7,Vaillancourt M.8,Nowland W.9,Daoud M.10,Qualls C.11,Harris S. B.12ORCID

Affiliation:

1. GlaxoSmithKline Philadelphia PA USA

2. Charles River Laboratories Ashland, OH USA

3. TAO DART Technical Consulting, LLC New Brunswick, NJ USA

4. Syngenta Limited Bracknell United Kingdom

5. Accelera S.r.l. Nerviano Italy

6. Labcorp Harrogate United Kingdom

7. Bristol Myers Squibb Company New Brunswick, NJ USA

8. CRL Laval Quebec Canada

9. Pfizer Inc Groton, CT USA

10. CRL Hertogenbosch The Netherlands

11. Labcorps Greenfield IN USA

12. Stephen B Harris Group San Diego, CA USA

Abstract

AbstractBackgroundA survey of laboratories in North American and Europe that routinely conduct fetal skeletal examinations was performed with the purpose of (1) understanding current terminology used for classifying skeletal findings in developmental toxicity (DT) studies and (2) understanding the criteria used to identify relatively common findings that sufficiently deviate from normal. The goal was to promote terminology harmonization and improve interlaboratory consistency in the criteria used to identify developmental anomalies.MethodsThe survey, designed based on terminology for developmental anomalies recommended by an international collaboration (Makris et al., Congenital Anomalies, 2009;49(3):123–246), was conducted by a subgroup (authors of this publication) of the Royal Society of Biology's International Register of Fetal Morphologists (IRFM).ResultsIndividual and summarized anonymized responses are provided here. The authors, who are expert fetal morphologists with experience performing fetal examinations, reviewed the responses and generated recommendations on preferred terminology and criteria for determining when morphological variations deviate from normal and warrant recording of the findings for skeletal observations in Sprague Dawley (SD) fetal rats. The objective of these recommendations is to complement Makris et al. (Congenital Anomalies, 2009;49(3):123–246).ConclusionThe broad application will improve interlaboratory harmonization of recording fetal skeleton findings in developmental toxicity studies intended for regulatory submissions, including SEND (Standard for Exchange of Nonclinical Data).

Publisher

Wiley

Subject

Health, Toxicology and Mutagenesis,Developmental Biology,Toxicology,Embryology,Pediatrics, Perinatology and Child Health

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3